Methodological considerations for centromere copy number analyses in HER2-positive metastatic breast cancer
16 April 2026 at 08:00
Oncogene, Published online: 16 April 2026; doi:10.1038/s41388-026-03793-x
Methodological considerations for centromere copy number analyses in HER2-positive metastatic breast cancer